645
Views
64
CrossRef citations to date
0
Altmetric
Original Articles

Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies

, , , , , , , , , , & show all
Pages 643-651 | Received 04 Mar 2011, Accepted 15 Feb 2012, Published online: 20 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gang Guo, Moushun Fu, Shuxiang Wei & Ruiwan Chen. (2018) Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis. OncoTargets and Therapy 11, pages 1193-1201.
Read now
Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now
Elizabeth A. Suarez, Carol E. Koro, Jennifer B. Christian, Alicia D. Spector, Andre B. Araujo & Sybil Abraham. (2014) Incretin-mimetic therapies and pancreatic disease: a review of observational data. Current Medical Research and Opinion 30:12, pages 2471-2481.
Read now

Articles from other publishers (61)

Vincenzo De Falco, Pasquale Vitale, Christian Brancati, Giuseppe Cicero, Annunziata Auriemma & Raffaele Addeo. (2023) Prognostic value of diabetes and metformin use in a real-life population of head and neck cancer patients. Frontiers in Medicine 10.
Crossref
Fanxiu Xiong, Qichen Dai, Sihan Zhang, Stephen Bent, Peggy Tahir, Erin L. Van Blarigan, Stacey A. Kenfield, June M. Chan, Gabriela Schmajuk & Rebecca E. Graff. (2023) Diabetes and incidence of breast cancer and its molecular subtypes: A systematic review and meta‐analysis. Diabetes/Metabolism Research and Reviews.
Crossref
Joanna Wojciechowska, Wojciech Krajewski, Tomasz Zatoński & Joel Rodriguez-Saldana. 2023. The Diabetes Textbook. The Diabetes Textbook 1041 1060 .
Runquan Zhou, Chenglu Huang, Zhilin Luo & Tianhu Wang. (2022) The Association between the Risk of Esophageal Cancer and Type 2 Diabetes Mellitus: An Updated Meta-Analysis. BioMed Research International 2022, pages 1-11.
Crossref
Kyeong-Min Lee, Yeo Jin Hwang & Gwon-Soo Jung. (2022) Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression. Biochemical and Biophysical Research Communications 626, pages 135-141.
Crossref
Andrés Bonilla-Sanchez, Jenny Rojas-Munoz & Herney Andrés Garcia-Perdomo. (2022) Association Between Diabetes and the Risk of Kidney Cancer: Systematic Review and Meta-Analysis. Clinical Diabetes 40:3, pages 270-282.
Crossref
Rajendra Prabhu Abhinav, Joanne Williams, Catherine Bennett, Patricia Livingston, Saravanan Jebarani, Rajendra Pradeepa, Ranjit Mohan Anjana & Viswanathan Mohan. (2022) Frequency and association of self-reported oral cancer among individuals with type 2 diabetes at a tertiary care diabetes centre in South India - A retrospective study. Journal of Diabetes and its Complications 36:3, pages 108129.
Crossref
Giovanna Esposito, Francesca Bravi, Diego Serraino, Fabio Parazzini, Anna Crispo, Livia S. A. Augustin, Eva Negri, Carlo La Vecchia & Federica Turati. (2021) Diabetes Risk Reduction Diet and Endometrial Cancer Risk. Nutrients 13:8, pages 2630.
Crossref
Suzanna Hutt, Denis Mihaies, Emmanouil Karteris, Agnieszka Michael, Annette M. Payne & Jayanta Chatterjee. (2021) Statistical Meta-Analysis of Risk Factors for Endometrial Cancer and Development of a Risk Prediction Model Using an Artificial Neural Network Algorithm. Cancers 13:15, pages 3689.
Crossref
Chin-Hsiao Tseng. (2021) The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature. Biomolecules 11:7, pages 1022.
Crossref
Pengfei Yan, Yongbo Wang, Xue Yu, Yu Liu & Zhi-Jiang Zhang. (2021) Type 2 diabetes mellitus and risk of head and neck cancer subtypes: a systematic review and meta-analysis of observational studies. Acta Diabetologica 58:5, pages 549-565.
Crossref
Lihai Wang, Lei Zhong, Bin Xu, Min Chen & Hongxiao Huang. (2020) Diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case–control studies. BMJ Open 10:12, pages e040137.
Crossref
Rajendra Prabhu Abhinav, Joanne Williams, Patricia Livingston, Ranjit Mohan Anjana & Viswanathan Mohan. (2020) Burden of diabetes and oral cancer in India. Journal of Diabetes and its Complications 34:11, pages 107670.
Crossref
Francesco Tovoli, Silvia Ferri & Fabio Piscaglia. (2020) Hepatocellular Carcinoma in Non Alcoholic Fatty Liver Disease. Current Pharmaceutical Design 26:32, pages 3909-3914.
Crossref
Matteo Di Maso, Francesca Bravi, Jerry Polesel, Eva Negri, Adriano Decarli, Diego Serraino, Carlo La Vecchia & Monica Ferraroni. (2019) Attributable fraction for multiple risk factors: Methods, interpretations, and examples. Statistical Methods in Medical Research 29:3, pages 854-865.
Crossref
Federica Turati, Carlotta Galeone, Livia S. A. Augustin & Carlo La Vecchia. (2019) Glycemic Index, Glycemic Load and Cancer Risk: An Updated Meta-Analysis. Nutrients 11:10, pages 2342.
Crossref
Federica Turati & Carlo La Vecchia. (2019) Liver enzymes and all‐cause mortality: Open issues. Liver International 39:8, pages 1389-1390.
Crossref
Amy Ming‐Fang Yen, Sen‐Te Wang, Bou‐Yue Peng, Ya‐Chung Cheng, Pallop Siewchaisakul, Chen‐Yang Hsu & Sam Li‐Sheng Chen. (2019) Impact of oral potentially malignant disorder subtypes on all‐cause and cause‐specific mortality in males. Oral Diseases 25:3, pages 750-757.
Crossref
Smadar Cohen Atsmoni, Avivit Brener & Yehudah Roth. (2019) Diabetes in the practice of otolaryngology. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:2, pages 1141-1150.
Crossref
Martijn J. L. Verhulst, Bruno G. Loos, Victor E. A. Gerdes & Wijnand J. Teeuw. (2019) Evaluating All Potential Oral Complications of Diabetes Mellitus. Frontiers in Endocrinology 10.
Crossref
Joanna Krajewska, Wojciech Krajewski & Tomasz Zatoński. 2019. The Diabetes Textbook. The Diabetes Textbook 919 937 .
Wang Yao, Yuqi Meng, Mingjian Lu, Wenzhe Fan, Jinhua Huang, Jiaping Li & Zhihua Zhu. (2018) Impact of type 2 diabetes mellitus on short‐term and long‐term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis. Cancer Communications 38:1, pages 1-9.
Crossref
Roy G.P.J. de Jong, Paul J.H.L. Peeters, Andrea M. Burden, Marie L. de Bruin, Harm R. Haak, Ad A.M. Masclee, Frank de Vries & Maryska L.G. Janssen-Heijnen. (2018) Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK. Cancer Epidemiology 54, pages 104-111.
Crossref
Bo Xu, Xiufang Zhou, Xiaohong Li, Chaoyang Liu & Caizhe Yang. (2017) Diabetes mellitus carries a risk of esophageal cancer. Medicine 96:35, pages e7944.
Crossref
A. Crispo, L.S.A. Augustin, M. Grimaldi, F. Nocerino, A. Giudice, E. Cavalcanti, M. Di Bonito, G. Botti, M. De Laurentiis, M. Rinaldo, E. Esposito, G. Riccardi, A. Amore, M. Libra, G. Ciliberto, D.J.A. Jenkins & M. Montella. (2017) Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular Subtypes. Journal of Cellular Physiology 232:5, pages 1144-1150.
Crossref
Michael Zvi Lerner, Niv Mor, Hyung Paek, Andrew Blitzer & Marshall Strome. (2017) Metformin Prevents the Progression of Dysplastic Mucosa of the Head and Neck to Carcinoma in Nondiabetic Patients. Annals of Otology, Rhinology & Laryngology 126:4, pages 340-343.
Crossref
Valentina Rosato, Alessandra Tavani, Esther Gracia-Lavedan, Elisabet Guinó, Gemma Castaño-Vinyals, Cristina M. Villanueva, Manolis Kogevinas, Jerry Polesel, Diego Serraino, Federica E. Pisa, Fabio Barbone, Victor Moreno, Carlo La Vecchia & Cristina Bosetti. (2016) Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case–Control Studies from Italy and Spain. Frontiers in Oncology 6.
Crossref
J. L. Dixon, L. A. Copeland, J. E. Zeber, A. A. MacCarthy, S. I. Reznik, W. R. Smythe & P. A. Rascoe. (2016) Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population. Diseases of the Esophagus 29:7, pages 747-751.
Crossref
Rejane Augusta de Oliveira Figueiredo, Elisabete Weiderpass, Eloiza Helena Tajara, Peter Ström, André Lopes Carvalho, Marcos Brasilino de Carvalho, Jossi Ledo Kanda, Raquel Ajub Moyses & Victor Wünsch-Filho. (2016) Diabetes mellitus, metformin and head and neck cancer. Oral Oncology 61, pages 47-54.
Crossref
Elisabetta Degasperi & Massimo Colombo. (2016) Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. The Lancet Gastroenterology & Hepatology 1:2, pages 156-164.
Crossref
. 2016. The Glycemic Index. The Glycemic Index 127 155 .
Mohammad Esmaeil Akbari, Saede Atarbashi Moghadam, Fazele Atarbashi Moghadam & Zahra Bastani. (2016) Malignant Tumors of Tongue in Iranian Population. Iranian Journal of Cancer Prevention 9:4.
Crossref
Andrea Gini, Ettore Bidoli, Loris Zanier, Elena Clagnan, Giorgio Zanette, Michele Gobbato, Paolo De Paoli & Diego Serraino. (2016) Cancer among patients with type 2 diabetes mellitus: A population-based cohort study in northeastern Italy. Cancer Epidemiology 41, pages 80-87.
Crossref
A. Crispo, M. Montella, G. Buono, M. Grimaldi, M. D’Aiuto, I. Capasso, E. Esposito, A. Amore, F. Nocerino, L.S.A. Augustin, A. Giudice, M. Di Bonito, M. Giuliano, V. Forestieri, M. De Laurentiis, M. Rinaldo, G. Ciliberto, S. De Placido & G. Arpino. (2016) Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women. Current Research in Translational Medicine 64:1, pages 15-20.
Crossref
Tessho Maruyama, Toshiyuki Nakasone, Nobuyuki Maruyama, Akira Matayoshi & Akira Arasaki. (2015) Synchronous quadruple multiple primary cancers of the tongue, bilateral breasts, and kidney in a female patient with a disease-free survival time of more than 5 years: a case report. World Journal of Surgical Oncology 13:1.
Crossref
Francesca Valent. (2015) Diabetes mellitus and cancer of the digestive organs: An Italian population-based cohort study. Journal of Diabetes and its Complications 29:8, pages 1056-1061.
Crossref
Shanshan Song, Baosheng Wang, Xin Zhang, Liliang Hao, Xianliang Hu, Zhongxiang Li & Shaolong Sun. (2015) Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis. PLOS ONE 10:7, pages e0134321.
Crossref
Cristina Bosetti, Matteo Franchi, Federica Nicotra, Rosario Asciutto, Luca Merlino, Carlo La Vecchia & Giovanni Corrao. (2015) Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases. Pharmacoepidemiology and Drug Safety 24:7, pages 771-778.
Crossref
Federica Turati, Carlotta Galeone, Sara Gandini, Livia S. Augustin, David J. A. Jenkins, Claudio Pelucchi & Carlo La Vecchia. (2015) High glycemic index and glycemic load are associated with moderately increased cancer risk. Molecular Nutrition & Food Research 59:7, pages 1384-1394.
Crossref
Yuhua Gong, Benjuan Wei, Li Yu & Weijuan Pan. (2015) Type 2 diabetes mellitus and risk of oral cancer and precancerous lesions: A meta-analysis of observational studies. Oral Oncology 51:4, pages 332-340.
Crossref
Janice S. Kwon. (2015) Improving survival after endometrial cancer: the big picture. Journal of Gynecologic Oncology 26:3, pages 227.
Crossref
Luca Miele, Cristina Bosetti, Federica Turati, Gianlodovico Rapaccini, Antonio Gasbarrini, Carlo La Vecchia, Stefania Boccia & Antonio Grieco. (2015) Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk. Gastroenterology Research and Practice 2015, pages 1-5.
Crossref
C. Becker, S. S. Jick, C. R. Meier & M. Bodmer. (2014) Metformin and the risk of head and neck cancer: a case-control analysis. Diabetes, Obesity and Metabolism 16:11, pages 1148-1154.
Crossref
Pu-Yun OuYang, Zhen Su, Jie Tang, Xiao-Wen Lan, Yan-Ping Mao, Wuguo Deng & Fang-Yun Xie. (2014) Diabetes, Prediabetes and the Survival of Nasopharyngeal Carcinoma: A Study of 5,860 Patients. PLoS ONE 9:10, pages e111073.
Crossref
C. Bosetti, V. Rosato, D. Li, D. Silverman, G.M. Petersen, P.M. Bracci, R.E. Neale, J. Muscat, K. Anderson, S. Gallinger, S.H. Olson, A.B. Miller, H. Bas Bueno-de-Mesquita, G. Scelo, V. Janout, I. Holcatova, P. Lagiou, D. Serraino, E. Lucenteforte, E. Fabianova, P.A. Baghurst, W. Zatonski, L. Foretova, E. Fontham, W.R. Bamlet, E.A. Holly, E. Negri, M. Hassan, A. Prizment, M. Cotterchio, S. Cleary, R.C. Kurtz, P. Maisonneuve, D. Trichopoulos, J. Polesel, E.J. Duell, P. Boffetta, C. La Vecchia & P. Ghadirian. (2014) Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Annals of Oncology 25:10, pages 2065-2072.
Crossref
Cristina Bosetti, Federica Turati & Carlo La Vecchia. (2014) Hepatocellular carcinoma epidemiology. Best Practice & Research Clinical Gastroenterology 28:5, pages 753-770.
Crossref
Pikli Batabyal, Stephen Vander Hoorn, Christopher Christophi & Mehrdad Nikfarjam. (2014) Association of Diabetes Mellitus and Pancreatic Adenocarcinoma: A Meta-Analysis of 88 Studies. Annals of Surgical Oncology 21:7, pages 2453-2462.
Crossref
Vlad C. Sandulache, John S. Hamblin, Heath D. Skinner, Mark W. Kubik, Jeffrey N. Myers & Jose P. Zevallos. (2014) Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma. Head & Neck 36:7, pages 1039-1043.
Crossref
Simple D. SinghA. Blythe RyersonManxia WuJudith S. Kaur. (2014) Ovarian and Uterine Cancer Incidence and Mortality in American Indian and Alaska Native Women, United States, 1999–2009. American Journal of Public Health 104:S3, pages S423-S431.
Crossref
Kathleen E. Corey & Lee M. Kaplan. (2014) Obesity and Liver Disease. Clinics in Liver Disease 18:1, pages 1-18.
Crossref
Vlad C. Sandulache, Liangpeng Yang & Heath D. Skinner. 2014. Cancer Cell Signaling. Cancer Cell Signaling 3 9 .
Carlo La Vecchia & Cristina Bosetti. (2013) Metformin: Are Potential Benefits on Cancer Risk Extended to Cancer Survival?. The Oncologist 18:12, pages 1245-1247.
Crossref
Kozue Nakamura, Keiko Wada, Yuya Tamai, Michiko Tsuji, Toshiaki Kawachi, Akihiro Hori, Naoharu Takeyama, Shinobu Tanabashi, Shogen Matsushita, Naoki Tokimitsu & Chisato Nagata. (2013) Diabetes mellitus and risk of cancer in Takayama: A population-based prospective cohort study in Japan. Cancer Science 104:10, pages 1362-1367.
Crossref
P. Bertuccio, C. Bosetti, F. Levi, A. Decarli, E. Negri & C. La Vecchia. (2013) A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Annals of Oncology 24:6, pages 1667-1674.
Crossref
. (2013) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 20:2, pages 156-160.
Crossref
Jung-Yun Lee, InPyo Jeon, Jae Weon Kim, Yong-Sang Song, Jae-Moon Yoon & Sang Min Park. (2013) Diabetes Mellitus and Ovarian Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies. International Journal of Gynecologic Cancer 23:3, pages 402-412.
Crossref
Cristina Bosetti, Francesca Bravi, Federica Turati, Valeria Edefonti, Jerry Polesel, Adriano Decarli, Eva Negri, Renato Talamini, Silvia Franceschi, Carlo La Vecchia & Maurice P. Zeegers. (2013) Nutrient-based dietary patterns and pancreatic cancer risk. Annals of Epidemiology 23:3, pages 124-128.
Crossref
Cristina BosettiValentina RosatoDanilo BuniatoAntonella Zambon, Carlo La VecchiaGiovanni Corrao. (2013) Cancer Risk for Patients Using Thiazolidinediones for Type 2 Diabetes: A Meta-Analysis. The Oncologist 18:2, pages 148-156.
Crossref
F Turati, R Talamini, C Pelucchi, J Polesel, S Franceschi, A Crispo, F Izzo, C La Vecchia, P Boffetta & M Montella. (2012) Metabolic syndrome and hepatocellular carcinoma risk. British Journal of Cancer 108:1, pages 222-228.
Crossref
Rosalyn D. Ferguson, Emily J. Gallagher, Eyal J. Scheinman, Rawan Damouni & Derek LeRoith. 2013. Hormones and Breast Cancer. Hormones and Breast Cancer 51 98 .
S.A. Müller, K. Bläuer, G. Ergin, F. Bergmann, K. Z'graggen, B.M. Schmied & A. Ulrich. (2012) Long-term in vitro culture of hamster pancreatic β-cells and induction of adenocarcinoma by treatment with N-nitrosobis(2-oxopropyl)amine. Pancreatology 12:4, pages 380-387.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.